A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 594,327 shares of TNDM stock, worth $23.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
594,327
Previous 18,227 3160.7%
Holding current value
$23.9 Million
Previous $539,000 3804.45%
% of portfolio
0.03%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$22.09 - $35.41 $12.7 Million - $20.4 Million
576,100 Added 3160.7%
594,327 $21 Million
Q4 2023

Feb 13, 2024

BUY
$14.28 - $31.03 $260,281 - $565,583
18,227 New
18,227 $539,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $68.97 $3.76 Million - $5.92 Million
-85,827 Reduced 56.01%
67,400 $3.23 Million
Q2 2022

Aug 12, 2022

BUY
$53.22 - $123.09 $6.99 Million - $16.2 Million
131,327 Added 599.67%
153,227 $9.07 Million
Q1 2022

May 13, 2022

SELL
$101.89 - $150.09 $237,098 - $349,259
-2,327 Reduced 9.6%
21,900 $2.55 Million
Q4 2021

Feb 11, 2022

SELL
$118.18 - $153.21 $25.4 Million - $33 Million
-215,319 Reduced 89.89%
24,227 $3.65 Million
Q3 2021

Nov 12, 2021

BUY
$93.51 - $129.4 $19.2 Million - $26.5 Million
205,119 Added 595.81%
239,546 $28.6 Million
Q2 2021

Aug 13, 2021

SELL
$77.0 - $100.19 $10.5 Million - $13.7 Million
-136,700 Reduced 79.88%
34,427 $3.35 Million
Q1 2021

May 13, 2021

SELL
$81.28 - $104.34 $11.8 Million - $15.2 Million
-145,300 Reduced 45.92%
171,127 $15.1 Million
Q4 2020

Feb 10, 2021

SELL
$86.4 - $121.75 $10.9 Million - $15.4 Million
-126,669 Reduced 28.59%
316,427 $30.3 Million
Q3 2020

Nov 13, 2020

SELL
$95.43 - $116.09 $37.4 Million - $45.5 Million
-392,332 Reduced 46.96%
443,096 $50.3 Million
Q2 2020

Aug 13, 2020

BUY
$60.05 - $98.92 $20.4 Million - $33.7 Million
340,500 Added 68.8%
835,428 $82.6 Million
Q1 2020

May 14, 2020

SELL
$47.37 - $90.04 $9 Million - $17.1 Million
-189,972 Reduced 27.74%
494,928 $31.8 Million
Q4 2019

Feb 13, 2020

SELL
$53.13 - $71.19 $32.3 Million - $43.3 Million
-608,727 Reduced 47.06%
684,900 $40.8 Million
Q3 2019

Nov 13, 2019

BUY
$57.11 - $73.3 $22.6 Million - $29 Million
395,700 Added 44.07%
1,293,627 $76.3 Million
Q2 2019

Aug 12, 2019

BUY
$54.41 - $71.7 $6.72 Million - $8.85 Million
123,500 Added 15.95%
897,927 $57.9 Million
Q1 2019

May 14, 2019

SELL
$32.25 - $73.56 $20.6 Million - $46.9 Million
-637,900 Reduced 45.17%
774,427 $49.2 Million
Q4 2018

Feb 13, 2019

BUY
$28.45 - $40.65 $40.2 Million - $57.4 Million
1,412,327 New
1,412,327 $53.6 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.58B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.